Effect of Deer Antler Extracts from Various Origins and Parts on the Hemopoietic Activity

Korean Journal of Pharmacognosy

Volumn 35, Issue 1, 2004, Pages 6-15

  Kim, Sung Hoon ^b   Lee, Hyo Jeong ^a   Park, Jeong Ran ^a   Kim, Hana ^a   Ahn, Kyoo Seok ^c   Choz, Deok Yeon ^c   Choi, Don Woong ^c  

^a Kyung Hee University   (South Korea)

^b Korea Food and Drug Administration   (South Korea)

^c NONE

Author keywords

CD34+; Cyclophosphamide; Deer; Hemopoetic effect

Indexed keywords

BETA ACTIN; CD34 ANTIGEN; CHINESE DRUG; CYCLOPHOSPHAMIDE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 3; STEM CELL FACTOR;

ARTICLE; BASOPHIL; BURST FORMING UNIT E; CELL DIFFERENTIATION; COLONY FORMING UNIT GEMM; DEER; EOSINOPHIL; FLUORESCENCE ACTIVATED CELL SORTING; HEMATOPOIESIS; HORN; NEUTROPHIL; NONHUMAN; SPECIES DIFFERENCE;

EID: 1942472028     PISSN: 02533073     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Suh, J.S. and Eun J.S. (1999) Phagocytic activity of ethyl alcohol farction of deer antler in murin peritoneal macrophage. Biol. Paharm Bull. 22(9): 932-935.
2. Won, D.H. (1994) The review of the specification and the compositions of velvets. Proc. Int. Symp. Cervi Parvum Cornu, 12-25.
3. Testa N.G. and Molineux, G. (1993) Hemopoiesis, 37-38, Oxford University Press.
4. Kim, S. H. and Kim, M. J. (1993) Biological effects of deer antler extracts on hematopoietic system. Korean J of BRM. 3(1): 23-30.
5. Bae, D. S. (1975) Efects of velvet of different levels on weight gain, feed efficiency and development of organs of chickens. Korean J of Anim. Sci. 17: 571-576.
6. Vaziri, H., Schater, F., Wei, L., Zhu, X., Effros, R., Cohen, D., and Harley, C.B. (1993) Loss of telomeric DNA during aging of normal and trisomy 21 human lymphocytes. Am. J. Hum. Genet., 52: 661-667.
7. Vaziri, H., Dranowska W., Allsopp, R.C., Thomas, TE., Harley, C.B., and Lansdorp. P.M. (1994). Evidencd for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age. Proc. Natl. Acad. Sci. USA. 91: 9857-9860.
8. Shpall, E.J. and Jones, R.B. (1994). Release of tumor cells from bone marrow. Blood, 83: 623-625.
9. + peripheral blood progenitor cells after introduction of a mutated dihydrofolate reductase cDNA via retroviral gene transfer. blood. 85: 566-574.
10. + cells yields expansions of multiple lineage progenitors for tarnsfusion support (Abstract). 235. 2nd international metting of ISHAGE.
11. Bradley, T.R. and Metcal, D. (1966). The growth of mouse bone marrow cells in vitro Aust. J. Exp. Biol. Med Sci. 44: 287.
12. Burgess, A.W., CAmakaris, J., and Metcalf, D. (1977). Purification and properties of 7-3. colony-stimulating factor from mouse lung-conditioned medium. J. Biol. Chem., 252: 1998.
13. Wong, G.G., Witek, J.S., and Temple, P.A. (1985). Human GM-CSF: molecular cloning of the complementary DNA and purification of the natural and recombinanat proteins. Science, 228: 810-815.
14. Dexter, T.M., Allen, T.D., and Lajtha, L.G. (1977). Conditions controlling the proliferation of haematopoietic stem cells in vitro. J. Cell Phys. 91: 335.
15. Gartner, S. and Kaplan, H.S. (1980). Long-term culture of human bone marrow cells. Proc. Natl. Acad. Sci. USA. 77: 4756-4759.
16. Moore, M.A.S. (1991). Clinical implications of positive and negative hematopoitic stem cell regulators. Blood, 78: 1.
17. Moore, M.A.S. (1991). The furture of cytokine combination therapy. Cancer, 67: 2718-2716.
18. Sheridan, W.P., Gegley, C.G., and Jutter, C. (1992). Effect of peripheral-blood progenitor cells mobilzed by filgrastim (GCSF) on platelet recovery after high-dose chemotherapy. Lancet. 339: 640-644.
19. Shapall, E.J., Jones, R.B., and Bearman, S.I. (1994). Transplantation of enriched CD34 positive autologous marrow into breast cancer patients following high-dose chemotherapy: influence of CD34-positive peripheral-blood progenitors and growth factors on engraftment. J. Clin. Oncol., 12: 28-36.
20. + cells unseparated peripheral blood progenitor cells mediate identical hematopoietic engraftment after high-dose VP-16, ifosfamide, carboplatin, and epirubicin. Blood, 84: 1421-1426.
21. Srour, E.F., Brandt, J.E., Briddell, R.A., Grigsby, S., Leemhuis, T., and Hoffman, R. (1993). Lomg-term generation and expansion of human primitive hematopoirtic progrnitor cells in vitro. Blood. 81: 661-669.
22. Koller, M.R., Emerson, S.G., and Palsson, B.O.(1993) Large-scale expansion of human stem and progenitor cells from bone marrow mononuclear cells in continuous perfusion cultures. Blood. 82: 378-384.
23. + cells into the myloid lineage. Blood, 80: 1405-1412.
24. +-selected human peripheral blood progenitor cells. Blood. 84: 2898-2903.
25. + cells. Blood. 82: 3600-3609.
26. + progenitor cells by stem cell factor, interleukin-1(IL-1), IL-6, IL-3, interferon-γ, and erythropoietin. Blood. 81: 2579-1584.
27. + cells from patients with stage IV breast cancer. Blood. 84: 3567-3574.
28. Hami, L., Greer, G., Greenfield, D., Steele, A., and Shapall, E. (1995) The ex-vivo expansion of CD34 purified cord blood progenitor cells (Abstract). 2nd International Meeting of ISHAGE, Proceeding. 235.
29. Brandt, J., Briddell, R.A., Srour, E.F., Leemhuis, T.B., and Hoffman, R. (1992). Role of c-kit lugand in the expansion of human hematopoietic progenitor cells. Blood. 79: 634-641.
30. Brugger, W., Heimfeld, S., Berenson, R., Mertelsmann, R., and Kanz, L. (1995) Reconstitution of hematopoiesis after high-dose chemotherapy by autologous progenitor cells generated ex vivo. N. Engl. J. Med. 333: 283-287.
31. Miltenyi, S., Meuller, W., Weichel, W., and Radbruch, A. (1990). High gradient magnetic cell separation with MACS. Cytometry, 11: 231-238.
32. Itoh K., et al. (1989). Reproducible establishment of hemopoietic supportive cell lines from murine bone marrow. Exp. Hematol. 17: 145.
33. ++/CD38-progenitor cells in long-term cultures and semisoid assays. Blood. 81: 2916.
34. Sutherland H.J., et al. (1989). Characterization and partial purification of human marrow cells capable of initiating long-term hamtopoiesis in vitro. Blood. 74: 1563.